While our study also revealed novel findings, such as a possible activation of the IL6-STAT-IDO pathway feedback loop or the cellular responses to hypoxia in cancer cell lines, these findings require further validation using orthogonal technologies, such as WB, IHC or ELISA. The gene discussed is IDO1; the disease is cancer.